AAAAAA

   
Results: 1-25 | 26-50 | 51-61
Results: 1-25/61
ANGIOGENIN EXPRESSION AND PROGNOSIS IN PRIMARY BREAST-CARCINOMA
Authors: MONTERO S GUZMAN C CORTESFUNES H COLOMER R
Citation: S. Montero et al., ANGIOGENIN EXPRESSION AND PROGNOSIS IN PRIMARY BREAST-CARCINOMA, Clinical cancer research, 4(9), 1998, pp. 2161-2168
THE PREDICTION OF RESPONSE TO CHEMOTHERAPY IN INVASIVE BREAST-CARCINOMA BY DETERMINATION OF HISTOLOGICAL GRADE
Authors: PINDER SE MURRAY S ELLIS IO TRIHIA H ELSTON CW GELBER RD GOLDHIRSCH A LINDTNER J CORTESFUNES H SIMONCINI E BYRNE MJ GOLOUH R RUDENSTAM CM CASTIGLIONEGERTSCH M
Citation: Se. Pinder et al., THE PREDICTION OF RESPONSE TO CHEMOTHERAPY IN INVASIVE BREAST-CARCINOMA BY DETERMINATION OF HISTOLOGICAL GRADE, European journal of cancer, 34, 1998, pp. 513-513
A PHASE-II STUDY OF A NOVEL GEMCITABINE PLUS CISPLATIN REGIMEN ADMINISTERED EVERY 3 WEEKS FOR ADVANCED NON-SMALL-CELL LUNG-CANCER
Authors: CASTELLANO D LIANES P PAZARES L HIDALGO M GUERRA JA GOMEZMARTIN C GOMEZ H CALZAS J CORTESFUNES H
Citation: D. Castellano et al., A PHASE-II STUDY OF A NOVEL GEMCITABINE PLUS CISPLATIN REGIMEN ADMINISTERED EVERY 3 WEEKS FOR ADVANCED NON-SMALL-CELL LUNG-CANCER, Annals of oncology, 9(4), 1998, pp. 457-459
SIGNIFICANT ACTIVITY OF THE MULTITARGETED ANTIFOLATE MTA (LY231514) IN ADVANCED TRANSITIONAL-CELL CARCINOMA (TCC) OF THE BLADDER - RESULTS OF A PHASE-II TRIAL
Authors: PAZARES L TABEMERO J MOYANO A RIFA J ALONSO S MARCUELLO E GONZALEZ A CASTELLANO D HEMANDEZ S CORTESFUNES H
Citation: L. Pazares et al., SIGNIFICANT ACTIVITY OF THE MULTITARGETED ANTIFOLATE MTA (LY231514) IN ADVANCED TRANSITIONAL-CELL CARCINOMA (TCC) OF THE BLADDER - RESULTS OF A PHASE-II TRIAL, Annals of oncology, 9, 1998, pp. 292-292
PHASE I II TRIAL OF ESCALATING-DOSE OF CYCLOPHOSPHAMIDE (C) IN COMBINATION WITH FIXED-DOSE OF PACLITAXEL (T) PLUS CISPLATIN (P) IN ADVANCEDOVARIAN-CANCER (AOC)/
Authors: MENDIOLA C CASTELLANO D GOMEZ H PEREZGRACIA JL ARCEDIANO A GOMEZMARTIN C PRONK L CORTESFUNES H
Citation: C. Mendiola et al., PHASE I II TRIAL OF ESCALATING-DOSE OF CYCLOPHOSPHAMIDE (C) IN COMBINATION WITH FIXED-DOSE OF PACLITAXEL (T) PLUS CISPLATIN (P) IN ADVANCEDOVARIAN-CANCER (AOC)/, Annals of oncology, 9, 1998, pp. 324-324
PROMISING ACTIVITY OF A NOVEL NON-CISPLATIN BASED REGIMEN IN ADVANCEDNONSMALL CELL LUNG-CANCER (NSCLC) - A PHASE-II STUDY OF GEMCITABINE (G), IFOSFAMIDE (I) PLUS VINORELBINE (N)
Authors: CASTELLANO D LIANES P ARCEDIANO A GARCIACARBONERO R PAZARES L GOMEZMARTIN C GUERRA JA CORTESFUNES H
Citation: D. Castellano et al., PROMISING ACTIVITY OF A NOVEL NON-CISPLATIN BASED REGIMEN IN ADVANCEDNONSMALL CELL LUNG-CANCER (NSCLC) - A PHASE-II STUDY OF GEMCITABINE (G), IFOSFAMIDE (I) PLUS VINORELBINE (N), Annals of oncology, 9, 1998, pp. 442-442
IMPROVEMENT OF DISEASE-RELATED SYMPTOMS WITH 2ND LINE OF GEMCITABINE IN ADVANCED NONSMALL CELL LUNG-CANCER (NSCLC)
Authors: GUERRA JA ARCEDIANO A LIANES P CASTELLANO D PAZARES L GOMEZMARTIN C CORTESFUNES H
Citation: Ja. Guerra et al., IMPROVEMENT OF DISEASE-RELATED SYMPTOMS WITH 2ND LINE OF GEMCITABINE IN ADVANCED NONSMALL CELL LUNG-CANCER (NSCLC), Annals of oncology, 9, 1998, pp. 457-457
INFECTIOUS COMPLICATIONS IN SOLID TUMORS PATIENTS AFTER HIGH-DOSE CHEMOTHERAPY (HDC) AND AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION (PBSCT)
Authors: ARCEDIANO A GOMEZMARTIN C HORNEDO J LUMBRERAS C GUERRA J GARCIACARBONERO R PEREZ J CORTESFUNES H
Citation: A. Arcediano et al., INFECTIOUS COMPLICATIONS IN SOLID TUMORS PATIENTS AFTER HIGH-DOSE CHEMOTHERAPY (HDC) AND AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION (PBSCT), Annals of oncology, 9, 1998, pp. 693-693
OXALIPLATIN AS SINGLE-AGENT IN PREVIOUSLY UNTREATED COLORECTAL-CARCINOMA PATIENTS - A PHASE-II MULTICENTRIC STUDY
Authors: DIAZRUBIO E SASTRE J ZANIBONI A LABIANCA R CORTESFUNES H DEBRAUD F BONI C BENAVIDES M DALLAVALLE G HOMERIN M
Citation: E. Diazrubio et al., OXALIPLATIN AS SINGLE-AGENT IN PREVIOUSLY UNTREATED COLORECTAL-CARCINOMA PATIENTS - A PHASE-II MULTICENTRIC STUDY, Annals of oncology, 9(1), 1998, pp. 105-108
RISK-FACTORS FOR TREATMENT-RELATED DEATH IN ELDERLY PATIENTS WITH AGGRESSIVE NON-HODGKINS-LYMPHOMA - RESULTS OF A MULTIVARIATE-ANALYSIS
Authors: GOMEZ H HIDALGO M CASANOVA L COLOMER R PEN DLK OTERO J RODRIGUEZ W CARRACEDO C CORTESFUNES H VALLEJOS C
Citation: H. Gomez et al., RISK-FACTORS FOR TREATMENT-RELATED DEATH IN ELDERLY PATIENTS WITH AGGRESSIVE NON-HODGKINS-LYMPHOMA - RESULTS OF A MULTIVARIATE-ANALYSIS, Journal of clinical oncology, 16(6), 1998, pp. 2065-2069
STANDARD VERSUS HIGH-DOSE THERAPY IN 10-CANCER - REPLY( BREAST)
Authors: GARCIACARBONERO R PAZARES L COLOMER R CORTESFUNES H
Citation: R. Garciacarbonero et al., STANDARD VERSUS HIGH-DOSE THERAPY IN 10-CANCER - REPLY( BREAST), Journal of clinical oncology, 16(2), 1998, pp. 810-811
HEART AND NEOPLASMS
Authors: CALZAS J LIANES P CORTESFUNES H
Citation: J. Calzas et al., HEART AND NEOPLASMS, Revista espanola de cardiologia, 51(4), 1998, pp. 314-331
FOCUS ON EPOETIN - KEY FINDINGS OF MINI-SESSIONS
Authors: LINKESCH WM PAYNE R MEDEN H CORTESFUNES H PANGALIS GA
Citation: Wm. Linkesch et al., FOCUS ON EPOETIN - KEY FINDINGS OF MINI-SESSIONS, Seminars in oncology, 25(3), 1998, pp. 69-75
THE IMPORTANCE OF THE HISTOLOGIC GRADE OF INVASIVE BREAST-CARCINOMA AND RESPONSE TO CHEMOTHERAPY
Authors: PINDER SE MURRAY S ELLIS IO TRIHIA H ELSTON GW GELBER RD GOLDHIRSCH A LINDTNER J CORTESFUNES H SIMONCINI E BYRNE MJ GOLOUH R RUDENSTAM CM CASTIGLIONEGERTSCH M GUSTERSON BA
Citation: Se. Pinder et al., THE IMPORTANCE OF THE HISTOLOGIC GRADE OF INVASIVE BREAST-CARCINOMA AND RESPONSE TO CHEMOTHERAPY, Cancer, 83(8), 1998, pp. 1529-1539
A MULTICENTER RANDOMIZED PHASE-II TRIAL OF GRANULOCYTE-COLONY-STIMULATING FACTOR-SUPPORTED, PLATINUM-BASED CHEMOTHERAPY WITH FLEXIBLE MIDCYCLE CISPLATIN ADMINISTRATION IN PATIENTS WITH ADVANCED OVARIAN-CARCINOMA
Authors: HIDALGO M MENDIOLA C LOPEZVEGA JM CASTELLANO D MENDEZ M BATISTEALENTON E LOPEZBREA M BELON J BATISTA JN CORTESFUNES H
Citation: M. Hidalgo et al., A MULTICENTER RANDOMIZED PHASE-II TRIAL OF GRANULOCYTE-COLONY-STIMULATING FACTOR-SUPPORTED, PLATINUM-BASED CHEMOTHERAPY WITH FLEXIBLE MIDCYCLE CISPLATIN ADMINISTRATION IN PATIENTS WITH ADVANCED OVARIAN-CARCINOMA, Cancer, 83(4), 1998, pp. 719-725
FAVORABLE PROGNOSIS AFTER LATE RELAPSE OF HODGKINS-DISEASE
Authors: GARCIACARBONERO R PAZARES L ARCEDIANO A LAHUERTA J BARTOLOME A CORTESFUNES H
Citation: R. Garciacarbonero et al., FAVORABLE PROGNOSIS AFTER LATE RELAPSE OF HODGKINS-DISEASE, Cancer, 83(3), 1998, pp. 560-565
PHARMACOKINETICS OF IRINOTECAN (CPT-11) AND 5-FLUOROURACIL (5-FU) IN A DOSE-FINDING STUDY IN ADULT PATIENTS WITH SOLID TUMORS
Authors: CARCAS AJ FRIAS J HERNANZ A RUBIO ED CORTESFUNES H SASTRE J PAZARES L VERNILLET L MARTIN C HUARTE L
Citation: Aj. Carcas et al., PHARMACOKINETICS OF IRINOTECAN (CPT-11) AND 5-FLUOROURACIL (5-FU) IN A DOSE-FINDING STUDY IN ADULT PATIENTS WITH SOLID TUMORS, European journal of cancer, 33, 1997, pp. 1121-1121
PHASE-I DOSE-FINDING STUDY OF IRINOTECAN (CPT-11) OVER A SHORT IV INFUSION COMBINED WITH A FIXED-DOSE OF 5-FLUOROURACIL (5-FU) PROTRACTED CONTINUOUS IV INFUSION IN PATIENTS WITH ADVANCED SOLID TUMORS
Authors: SASTRE J PAZARES L DIAZRUBIO E CORTESFUNES H CARCAS A GRUIA G HERAIT P FDZCHACON C MARTIN C FARR I
Citation: J. Sastre et al., PHASE-I DOSE-FINDING STUDY OF IRINOTECAN (CPT-11) OVER A SHORT IV INFUSION COMBINED WITH A FIXED-DOSE OF 5-FLUOROURACIL (5-FU) PROTRACTED CONTINUOUS IV INFUSION IN PATIENTS WITH ADVANCED SOLID TUMORS, European journal of cancer, 33, 1997, pp. 1141-1141
FAVORABLE PROGNOSIS AFTER LATE RELAPSE IN HODGKINS-DISEASE
Authors: GARCIACARBONERO R ARCEDIANO A PAZARES C LAHUERTA J COLOMER R CORTESFUNES H
Citation: R. Garciacarbonero et al., FAVORABLE PROGNOSIS AFTER LATE RELAPSE IN HODGKINS-DISEASE, European journal of cancer, 33, 1997, pp. 1190-1190
A DECADE OF CLINICAL INVESTIGATION IN ELDERLY PATIENTS WITH NON-HODGKINS-LYMPHOMA - RESULTS AS REPORTED IN THE LITERATURE
Authors: GOMEZ H COLOMER R CASTTELLANOS D CORTESFUNES H
Citation: H. Gomez et al., A DECADE OF CLINICAL INVESTIGATION IN ELDERLY PATIENTS WITH NON-HODGKINS-LYMPHOMA - RESULTS AS REPORTED IN THE LITERATURE, European journal of cancer, 33, 1997, pp. 1205-1205
COMBINATION OF ORAL IDARUBICIN AND PREDNIMUSTINE IN ADVANCED BREAST-CANCER - A PHASE-II STUDY
Authors: BARNADAS A MENDIOLA C CASADO A VILLAR A JIMENO J CLERIGUE M ROSELL R DIAZRUBIO E CORTESFUNES H DEPAREDES MG
Citation: A. Barnadas et al., COMBINATION OF ORAL IDARUBICIN AND PREDNIMUSTINE IN ADVANCED BREAST-CANCER - A PHASE-II STUDY, European journal of cancer, 33(2), 1997, pp. 312-315
SHOULD PROPHYLACTIC SURGERY BE USED IN WOMEN WITH HIGH-RISK OF BREAST-CANCER - ARBITER
Authors: CORTESFUNES H COLOMER R
Citation: H. Cortesfunes et R. Colomer, SHOULD PROPHYLACTIC SURGERY BE USED IN WOMEN WITH HIGH-RISK OF BREAST-CANCER - ARBITER, European journal of cancer, 33(13), 1997, pp. 2158-2159
SAFETY PROFILE OF GEMCITABINE, A NOVEL ANTICANCER AGENT, IN NONSMALL CELL LUNG-CANCER
Authors: CORTESFUNES H MARTIN C ABRATT R LUND B
Citation: H. Cortesfunes et al., SAFETY PROFILE OF GEMCITABINE, A NOVEL ANTICANCER AGENT, IN NONSMALL CELL LUNG-CANCER, Anti-cancer drugs, 8(6), 1997, pp. 582-587
MEDIASTINAL NONSEMINOMATOUS GERM-CELL TUMORS (MNSGCT) TREATED WITH CISPLATIN-BASED COMBINATION CHEMOTHERAPY
Authors: HIDALGO M PAZARES L RIVERA F LIANES P HUIDOBRO G RUIZ A LOPEZBREA M SANZORTIZ J LOPEZ JL CORTESFUNES H TABERNERO JM
Citation: M. Hidalgo et al., MEDIASTINAL NONSEMINOMATOUS GERM-CELL TUMORS (MNSGCT) TREATED WITH CISPLATIN-BASED COMBINATION CHEMOTHERAPY, Annals of oncology, 8(6), 1997, pp. 555-559
PROGNOSTIC IMPORTANCE OF THYMIDYLATE SYNTHASE EXPRESSION IN EARLY BREAST-CANCER
Authors: PESTALOZZI BC PETERSON HF GELBER RD GOLDHIRSCH A GUSTERSON BA TRIHIA H LINDTNER J CORTESFUNES H SIMMONCINI E BYRNE MJ GOLOUH R RUDENSTAM CM CASTIGLIONEGERTSCH M ALLEGRA CJ JOHNSTON PG
Citation: Bc. Pestalozzi et al., PROGNOSTIC IMPORTANCE OF THYMIDYLATE SYNTHASE EXPRESSION IN EARLY BREAST-CANCER, Journal of clinical oncology, 15(5), 1997, pp. 1923-1931
Risultati: 1-25 | 26-50 | 51-61